Compassionate Allowances In Social Security Disability Claims

Compassionate Allowances can allow your SSDI or SSI claim to be fast-tracked

Social Security utilizes an important tool that provides benefits quickly to applicants whose medical conditions are so serious that they obviously meet disability standards. Compassionate Allowances allows SSA to quickly identify diseases and other medical conditions that clearly qualify under the Listing of Impairments due to their severity.

SSA utilizes a variety of information to determine which conditions qualify for Compassionate Allowance treatment. Input utilized by SSA includes information received at public outreach hearings, comments received from the Social Security and Disability Determination Service communities, opinions of medical and scientific experts, and research with the National Institutes of Health. The list of Compassionate Allowance conditions is continually updated and has been expanded considerably. Most recently, SSA added 52 new Compassionate Allowance conditions, including conditions involving cancers, neurological, and immune system disorders affecting adults and children. The new conditions became effective August 11, 2012.

Do I Get Higher Benefit Amounts If I Qualify Under A Compassionate Allowance?

Just because you qualify for disability under a Compassionate Allowance, your benefit calculations are exactly the same. Basically, nothing changes except you are approved more quickly. Under the SSDI program, you still need to wait 5 months from the date you are found to be disabled under SSA rules until your date of entitlement to benefits, and you need to wait 24 months again from the date of entitlement to benefits before you are eligible for Medicare. Under the SSI program, you are eligible for monthly financial benefits from the date you filed your claim for benefits. Under SSI you are eligible for Medicaid immediately upon approval of your claim.

List of Compassionate Allowances

• Acute Leukemia 
• Adrenal Cancer – with distant metastases or inoperable, unresectable or recurrent
• Adult Non-Hodgkin Lymphoma
•  Adult Onset Huntington Disease
•  Aicardi-Goutieres Syndrome
• Alexander Disease (ALX) – Neonatal and Infantile
• Allan-Herndon-Dudley Syndrome 
• Alobar Holoprosencephaly
• Alpers Disease 
• Alpha Mannosidosis – Type II and III 
• Alstrom Syndrome 
• Alveolar Soft Part Sarcoma 
• Amegakaryocytic Thrombocytopenia 
• Amyotrophic Lateral Sclerosis (ALS) 
• Anaplastic Adrenal Cancer – with distant metastases or inoperable, unresectable or recurrent
• Angelman Syndrome
• Aortic Atresia 
• Aplastic Anemia 
• Astrocytoma – Grade III and IV 
• Ataxia Telangiectasia 
• Batten Disease 
• Beta Thalassemia Major 
• Bilateral Optic Atrophy- Infantile 
• Bilateral Retinoblastoma 
• Bladder Cancer – with distant metastases or inoperable or unresectable
• Breast Cancer – with distant metastases or inoperable or unresectable
• Canavan Disease (CD)
• Carcinoma of Unknown Primary Site
• Caudal Regression Syndrome – Types III and IV 
• Cerebro Oculo Facio Skeletal (COFS) Syndrome 
• Cerebrotendinous Xanthomatosis 
• Child Neuroblastoma – with distant metastases or recurrent
• Child Non-Hodgkin Lymphoma – recurrent
• Child T-Cell Lymphoblastic Lymphoma 
• Chondrosarcoma – with multimodal therapy
• Chronic Myelogenous Leukemia (CML) – Blast Phase 
• Congenital Lymphedema 
• Cornelia de Lange Syndrome 
• Corticobasal Degeneration 
• Creutzfeldt-Jakob Disease (CJD) – Adult 
• Cri du Chat Syndrome 
• Degos Disease – Systemic
• DeSanctis Cacchione Syndrome 
• Dravet Syndrome 
• Early-Onset Alzheimer’s Disease
• Edwards Syndrome (Trisomy 18) 
• Eisenmenger Syndrome 
• Endometrial Stromal Sarcoma 
• Endomyocardial Fibrosis 
• Ependymoblastoma (Child Brain Tumor)
• Erdheim Chester Disease 
• Esophageal Cancer 
• Ewing Sarcoma
• Farber’s Disease (FD) – Infantile 
• Fatal Familial Insomnia 
• Fibrodysplasia Ossificans Progressiva 
• Follicular Dendritic Cell Sarcoma – metastatic or recurrent
• Friedreichs Ataxia (FRDA)
• Frontotemporal Dementia (FTD), Picks Disease -Type A – Adult 
• Fryns Syndrome 
• Fucosidosis – Type 1 
• Fukuyama Congenital Muscular Dystrophy 
• Fulminant Giant Cell Myocarditis 
• Galactosialidosis – Early and Late Infantile Types 
• Gallbladder Cancer 
• Gaucher Disease (GD) – Type 2 
• Glioblastoma Multiforme (Adult Brain Tumor) 
• Glioma Grade III and IV 
• Glutaric Acidemia – Type II 
• Head and Neck Cancers – with distant metastasis or inoperable or unresectable
• Heart Transplant Graft Failure 
• Heart Transplant Wait List – 1A/1B 
• Hemophagocytic Lymphohistiocytosis (HLH) – Familial Type 
• Hepatoblastoma
• Hepatopulmonary Syndrome 
• Hepatorenal Syndrome 
• Histiocytosis Syndromes 
• Hutchinson-Gilford Progeria Syndrome 
• Hydranencephaly
• Hypocomplementemic Urticarial Vasculitis Syndrome 
• Hypophosphatasia Perinatal (Lethal) and Infantile Onset Types
• Hypoplastic Left Heart Syndrome
• I Cell Disease 
• Idiopathic Pulmonary Fibrosis 
• Infantile Free Sialic Acid Storage Disease 
• Infantile Neuroaxonal Dystrophy (INAD)
• Infantile Neuronal Ceroid Lipofuscinoses 
• Inflammatory Breast Cancer (IBC) 
• Jervell and Lange-Nielsen Syndrome 
• Junctional Epidermolysis Bullosa – Lethal Type 
• Juvenile Onset Huntington Disease 
• Kidney Cancer – inoperable or unresectable
• Krabbe Disease (KD) – Infantile 
• Kufs Disease – Type A and B 
• Large Intestine Cancer – with distant metastasis or inoperable, unresectable or recurrent
• Late Infantile Neuronal Ceroid Lipofuscinoses 
• Left Ventricular Assist Device (LVAD) Recipient 
• Leigh’s Disease
• Leiomyosarcoma 
• Lesch-Nyhan Syndrome (LNS) 
• Lewy Body Dementia 
• Lissencephaly 
• Liver Cancer 
• Lowe Syndrome 
• Lymphomatoid Granulomatosis – Grade III 
• Malignant Brain Stem Gliomas – Childhood 
• Malignant Gastrointestinal Stromal Tumor 
• Malignant Germ Cell Tumor 
• Malignant Melanoma – with metastases 
• Malignant Multiple Sclerosis 
• Mantle Cell Lymphoma (MCL) 
• Maple Syrup Urine Disease 
• Mastocytosis – Type IV 
• MECP2 Duplication Syndrome 
• Medulloblastoma – with metastases 
• Menkes Disease – Classic or Infantile Onset Form 
• Merkel Cell Carcinoma – with metastases 
• Merosin Deficient Congenital Muscular Dystrophy
• Metachromatic Leukodystrophy (MLD) – Late Infantile
• Mitral Valve Atresia 
• Mixed Dementias 
• MPS I, formerly known as Hurler Syndrome 
• MPS II, formerly known as Hunter Syndrome 
• MPS III, formerly known as Sanfilippo Syndrome 
• Mucosal Malignant Melanoma 
• Multicentric Castleman Disease 
• Multiple System Atrophy 
• Myoclonic Epilepsy with Ragged Red Fibers Syndrome 
• Neonatal Adrenoleukodystrophy 
• Nephrogenic Systemic Fibrosis 
• Neurodegeneration with Brain Iron Accumulation – Types 1 and 2 
• NFU-1 Mitochondrial Disease 
• Niemann-Pick Disease (NPD) – Type A 
• Niemann-Pick Disease-Type C 
• Nonketotic Hyperglycinemia 
• Non-Small Cell Lung Cancer – with metastases to or beyond the hilar nodes or inoperable, unresectable or recurrent
• Obliterative Bronchiolitis 
• Ohtahara Syndrome 
• Ornithine Transcarbamylase (OTC) Deficiency 
• Orthochromatic Leukodystrophy with Pigmented Glia 
• Osteogenesis Imperfecta (OI) – Type II 
• Osteosarcoma, formerly known as Bone Cancer – with distant metastases or inoperable or unresectable
• Ovarian Cancer – with distant metastases or inoperable or unresectable
• Pancreatic Cancer
• Paraneoplastic Pemphigus 
• Patau Syndrome (Trisomy 13) 
• Pearson Syndrome 
• Pelizaeus-Merzbacher Disease-Classic Form 
• Pelizaeus-Merzbacher Disease-Connatal Form 
• Peripheral Nerve Cancer – metastatic or recurrent 
• Peritoneal Mesothelioma 
• Peritoneal Mucinous Carcinomatosis 
• Perry Syndrome 
• Phelan-McDermid Syndrome 
• Pleural Mesothelioma 
• Pompe Disease – Infantile
• Primary Cardiac Amyloidosis 
• Primary Central Nervous System Lymphoma 
• Primary Effusion Lymphoma 
• Primary Progressive Aphasia 
• Progressive Multifocal Leukoencephalopathy 
• Progressive Supranuclear Palsy 
• Pulmonary Atresia 
• Pulmonary Kaposi Sarcoma 
• Retinopathy of Prematurity – Stage V 
• Rett (RTT) Syndrome 
• Rhabdomyosarcoma 
• Rhizomelic Chondrodysplasia Punctata 
• Roberts Syndrome 
• Salivary Tumors 
• Sandhoff Disease 
• Schindler Disease – Type 1 
• Severe Combined Immunodeficiency – Childhood 
• Single Ventricle 
• Sinonasal Cancer 
• Small Cell Cancer (of the Large Intestine, Ovary, Prostate, or Uterus)
• Small Cell Lung Cancer 
• Small Intestine Cancer – with distant metastases or inoperable, unresectable or recurrent
• Smith Lemli Opitz Syndrome 
• Spinal Muscular Atrophy (SMA) – Types 0 and 1
• Spinal Nerve Root Cancer-metastatic or recurrent 
• Spinocerebellar Ataxia
• Stiff Person Syndrome 
• Stomach Cancer – with distant metastases or inoperable, unresectable or recurrent
• Subacute Sclerosing Panencephalitis 
• Tabes Dorsalis 
• Tay Sachs Disease – Infantile Type 
• Thanatophoric Dysplasia – Type 1 
• The ALS/Parkinsonism Dementia Complex 
• Thyroid Cancer
• Transplant Coronary Artery Vasculopathy 
• Tricuspid Atresia 
• Ullrich Congenital Muscular Dystrophy 
• Ureter Cancer – with distant metastases or inoperable, unresectable or recurrent
• Usher Syndrome – Type I 
• Walker Warburg Syndrome 
• Wolf-Hirschhorn Syndrome 
• Wolman Disease
• Xeroderma Pigmentosum 
• Zellweger Syndrome
  
  

We Can Help You Get Approved Under The Compassionate Allowance Program

If you believe you may qualify under a Compassionate Allowance, please contact us so we can determine if you do, in fact, meet these requirements. We will do everything possible to get your claim approved quickly.

Share via: